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Abstract
 
Nonreciprocal translocations and gene amplifications are commonly found in human tumors.
Although little is known about the mechanisms leading to such aberrations, tissue culture models
predict that they can arise from DNA breakage, followed by cycles of chromatid fusion,
asymmetric mitotic breakage, and replication. Mice deficient in both a nonhomologous end
joining (NHEJ) DNA repair protein and the p53 tumor suppressor develop lymphomas at an
early age harboring amplification of an IgH/c-myc fusion. Here we report that these chromosomal
rearrangements are initiated by a recombination activating gene (RAG)-induced DNA
cleavage. Subsequent DNA repair events juxtaposing IgH and c-myc are mediated by a
break-induced replication pathway. Cycles of breakage-fusion-bridge result in amplification
of IgH/c-myc while chromosome stabilization occurs through telomere capture. Thus, mice
deficient in NHEJ provide excellent models to study the etiology of unbalanced translocations
and amplification events during tumorigenesis.
Key words: nonreciprocal translocations • gene ampliﬁcation • bridge-fusion breakage • 
nonhomologous end-joining • tumorigenesis
 
Introduction
 
Genomic instability is a hallmark of cancer. Human
hematopoietic malignancies are characterized by reciprocal
translocations that juxtapose oncogenes and antigen receptor
loci or create oncogenic fusion proteins. By contrast, solid
tumors commonly contain a much more complex karyo-
type, consisting of nonreciprocal translocations, which
typically result in chromosomal gains, losses and gene
amplifications. Such chromosomal imbalances promote
tumorigenesis by the underexpression of tumor suppressor
genes as well as disregulated expression of oncogenes.
Although studies in vitro have shown that site-specific
breaks may be the initiating lesion that triggers these
events (1, 2), the mechanisms leading to gross chromosomal
rearrangements remain to be characterized.
Nonhomologous end joining (NHEJ)
 
*
 
 components,
including Ku70, Ku80, DNA-PKcs, DNA ligase IV,
Xrcc4, and Artemis, are essential for the repair of double-
strand breaks (DSBs) during V(D)J recombination (3).
Additionally, this DNA repair pathway has been implicated
in maintaining genomic integrity via suppression of
chromosomal rearrangements (4–6). Consistent with this
idea, mice deficient in NHEJ components are characterized
by increased sensitivity to DNA damaging agents, chromo-
somal instability, immunodeficiency, and predisposition to
thymic lymphomas (3). Further loss of cell cycle checkpoints
in NHEJ-deficient mice results in a shift from thymomas to
pro-B cell lymphomas (4, 7–12) or to sarcomas (10, 13).
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Defects in NHEJ components have also been observed in
patients with multiple myelomas (14), leukemia (15), and a
disorder resembling Nijmegen breakage syndrome (NBS)
(16). Thus, loss of the NHEJ repair pathway has implications
in a broad spectrum of tumor types.
To understand the mechanisms by which aberrant chro-
mosome rearrangements occur in the absence of NHEJ, we
molecularly characterized pro-B cell lymphomas from mice
deficient for Ku and p53. All of these tumors harbor coam-
plification of the IgH and c-myc loci on either derivative
chromosomes 12 or 15 (4). Our data provide evidence that
unresolved RAG-mediated breaks during V(D)J recombi-
nation trigger a nonreciprocal replication pathway (i.e.,
break-induced-replication), leading to the juxtaposition of
IgH and c-myc loci. Subsequent attempts to stabilize the
end of the derivative chromosome result in amplification of
these genes by cycles of breakage-fusion-bridge and cap-
ture of telomere sequences from other chromosomes.
 
Materials and Methods
 
Generation and Screening of Mice.
 
Ku70 mutant mice were
generously provided by Dr. Fred Alt, The Children’s Hospital
and The Center for Blood Research, Boston, MA (17). p53
 
 
 
/
 
 
 
mice were obtained from Taconic Laboratories, and p53 geno-
typing was performed as described (18, 19). Mice heterozygous
for Ku70 and p53 were crossed to obtain progeny homozygous
for both Ku70 and p53 null alleles. Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 mice were
described previously (4) while the Ku80
 
 
 
/
 
 
 
 mice were generated
by intercrossing Ku80
 
 
 
/
 
 
 
ATM
 
 
 
/
 
 
 
 mice and were either het-
erozygous or homozygous wild-type at the ATM locus. Mice
heterozygous for Ku80 and p53 (20) were bred with Rad54
 
 
 
/
 
 
 
mice (21) to obtain F1 Rad54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 offspring. The
Rad54 mutation was fixed by crossbreeding F1 animals. Rag2
 
 
 
/
 
 
 
mice were purchased from Taconic Laboratories.
 
Spectral Karyotyping and FISH.
 
Suspensions of tumor cells
were grown in RPMI plus 10% FBS plus 50 U/ml of IL-7 (R&D
Systems) and 20 U/ml of IL-2 (Boehringer). Tumor cells were ar-
rested at mitosis with Colcemid (GIBCO BRL) treatment at 0.1
 
 
 
g/ml for 0.5–3 h. Mitotic chromosome spreads were prepared
following standard procedures, and Spectral Karyotype (SKY) anal-
ysis was performed as described (22). For FISH analysis, metaphases
were hybridized with BAC probes for the following regions: IgH
C
 
 
 
 (from C
 
 
 
1 to 3
 
 
 
 of C
 
 
 
) and IgH C
 
 
 
 were obtained by PCR
screening of a BAC library with gene-specific primers (22), IgH
variable region representing the distal end of the V cluster (VJ588)
(provided by Dr. Riblet, Torrey Pines Institute for Molecular
Studies, San Diego, CA), c-myc, 15 subtelomeric region, and two
BAC clones containing the breakpoint of chromosome 15 ob-
served in PKT2 (see below). Flow sorted single chromosomes
were used for painting probes. A telomere repeat-specific peptide
nucleic acid (PNA) probe labeled with Cy3 (Applied Biosystems)
was hybridized with PCR-generated chromosome-specific paint-
ing probes in 50% Formamide/20% dextran sulfate/2
 
  
 
SSC at
37
 
 
 
C overnight. Slides were then washed three times in 50% For-
mamide/2
 
  
 
SSC at 37
 
 
 
C, 2 times in 0.1
 
  
 
SSC at 60
 
 
 
C, and fi-
nally in 4
 
  
 
SSC/Tween 20 at 37
 
 
 
C. Slides were then processed
following standard FISH detection of the painting probes.
 
Sequencing of Breakpoints and Identification of BAC Clones.
 
The
breakpoint fusion from tumors PKT2, PKT7, and PKT13 were
obtained by digestion circularization PCR (4, 23). A search of
the mouse database with the breakpoint sequences enabled us to
determine which bases were derived from chromosomes 12 and
15 and to determine the proximity and orientation of these se-
quences with regard to the c-myc gene. BAC clones for mapping
of the breakpoints were obtained by screening the RPCI-23
mouse BAC library with a 23-mer oligonucleotide derived from
the 174-bp chromosome 15-specific sequence at the PKT2
breakpoint. Fingerprint analysis enabled the selection of clones
with a minimum overlap as well as clones in the contig that pro-
vided the largest coverage.
 
Results
 
Ku80
 
 
 
/
 
  
 
Thymic Lymphomas.
 
Several mouse strains
(Ku70
 
 
 
/
 
 
 
, Ku80
 
 
 
/
 
 
 
, SCID, ATM
 
 
 
/
 
 
 
, PARP
 
 
 
/
 
 
 
) deficient
in V(D)J recombination and/or DNA damage responses
are susceptible to thymic lymphomas (4, 10, 17, 24–27).
Cytogenetic analysis has only been described for ATM
 
 
 
/
 
 
 
lymphomas, where failure to correctly resolve V(D)J-
induced double strand breaks at the TCR
 
 
 
/
 
 
 
 locus in de-
veloping thymocytes results in the translocation of chromo-
some 14 to other chromosomes (22, 24). Ku80-deficient
mice succumb at a low frequency to late onset develop-
ment of thymic lymphomas. FACS
 
®
 
 analysis of cell surface
markers indicates that Ku80
 
 
 
/
 
 
 
 tumors arose during the
double positive CD4
 
 
 
CD8
 
 
 
stage of T cell (Thy1.2
 
 
 
) de-
velopment (not shown), similar to the phenotype observed
in ATM
 
 
 
/
 
 
 
 mice. Analysis of six Ku80
 
 
 
/
 
 
 
 tumors revealed
that although chromosome 14 was sometimes rearranged to
other chromosomes (L796 and L2283), none of these trans-
location events involved either the TCR
 
 
 
 or TCR
 
 
 
 loci
(Table I). These results differ from those in ATM
 
 
 
/
 
 
 
 thy-
momas (22) despite heterozygosity for the ATM gene in
three of the mice. Thus, the absence of Ku80 at RAG-
induced DSB during V(D)J recombination in developing T
cells does not result in the aberrant ligation of TCR loci to
another chromosome, as in ATM-deficient mice (22). A
full description of the karyotype can be found at http://
www.ncbi.nlm.nih.gov/sky/skyweb.cgi.
 
IgH/c-myc Rearrangements Are Independent of Rad54 but
Require Rag-mediated Cleavage.
 
On a p53-null back-
ground, loss of Ku70 promotes the rapid onset of pro-B
cell lymphomas associated with rearrangement and amplifi-
cation of IgH and c-myc loci (Table I). Alternative DNA
repair pathways, such as homologous recombination
(HR) could facilitate promiscuous chromosomal fusions in
NHEJ/p53-deficient mice. To assess the role of Rad54-
mediated HR in lymphoma development, we generated
Rad54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 and Rad54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
mice. 20% of Rad54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 mice died be-
tween the ages of 3–5 mo of thymic lymphoma (Table I).
Similar to Ku80
 
 
 
/
 
 
 
 thymic lymphomas, Rad54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 tumors did not contain translocations involving
TCR
 
 
 
 or TCR
 
 
 
 loci (Table I). A shift to the rapid devel-
opment of pro-B cell lymphomas, however, occurred in
RAD54
 
 
 
/
 
 
 
Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 mice. These tumors were sim-
ilar to the Ku
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 pro-B cell lymphomas in that they
contained translocations involving chromosomes 12 and 
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15. Probes complementary to the IgH C
 
 
 
 and c-myc genes
further demonstrated the juxtaposition and amplification of
these genes in each tumor (Table I; see below). These re-
sults indicate that certain aspects of HR, such as Rad54-
dependent sister chromatid exchanges (28), are not re-
quired for the chromosomal rearrangements characteristic
of NHEJ/p53-deficient B-lineage tumors.
The IgH locus in the mouse is oriented such that tran-
scription initiates at the telomeric V regions and proceeds
downstream toward the more centromeric constant regions
(see Fig. 4). In Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
 lymphomas, chromosome
15 was translocated to chromosome 12 upstream of the JH
segments while the more telomeric variable (VH) region
was lost, suggesting that these events were initiated by
Rag-mediated cleavage (4). To directly test the require-
ment for V(D)J recombination in the generation of pro-B
cell lymphomas, we generated Ku80
 
 
 
/
 
 
 
p53
 
 
 
/
 
 
 
RAG2
 
 / 
mice. These mice did not succumb to pro-B cell lympho-
mas, but unexpectedly, developed thymic lymphomas at
approximately the same time (3 mo) that pro-B cell lym-
Table I. Karyotypic Analysis of Pro-B and T Cell Lymphomas
Locus
involvement Amplification
Tumor
no. Genotype Immunophenotype Composite karyotype TCR IgH
Age of
onset IgH c-myc
L796 Ku80 / ATM /  Thymic lymphoma 39,X,-X, or Y, T(2:13)(B;C1),Rb(7.15),T(13;2)(B;B), 15 No n.d. 7 mo No No
L2282 Ku80 / ATM /  Thymic lymphoma 40,XX.T(3;14)(H4;E3) No n.d. 6 mo No No
L2283 Ku80 / ATM /  Thymic lymphoma 40,XX,T(7;14)(B;D),Rb(13.17),T(14;7)(C;C), 15 No n.d. 13 mo No No
L387 Ku80 / ATM /  Thymic lymphoma 42,XY,del(12)(F), Rb(14.14),-14[2], 15 No n.d. 7 mo No No
L2240 Ku80 / ATM /  Thymic lymphoma 40,XX,Rb(5,18)[1],Rb(13.14)[1],Rb(15.15), 15 No n.d. 8 mo No No
L3835 Ku80 / ATM /  Thymic lymphoma 42,X,T(X;4)(F;C),del(13)(A2→A5), 15, T(15;1)(C;D) No n.d. 7 mo No No
PKT1 Ku80 / p53 /  Pro-B cell lymphoma 39–49,XY, 1, 5,T(12;15;3;[1]) OR T(12;15;3)x2, 14 n.d. Yes 2 mo Yes Yes
PKT2 Ku80 / p53 /  Pro-B cell lymphoma 39–41,XX, 3,T(12;15),dup(15) n.d. Yes 2 mo Yes Yes
PKT3 Ku80 / p53 /  Pro-B cell lymphoma 38–42,XY,T(12;15),T(15;12) OR T(15;12;16) n.d. Yes 2 mo Yes Yes
PKT4 Ku80 / p53 /  Pro-B cell lymphoma 39–40,XY,T(12;15),T(15;12),dup(16) n.d. Yes 2 mo Yes Yes
PKT5–13 Ku80 / p53 /  Pro-B cell lymphoma n.d. n.d. Yes 2 mo Yes Yes
PK7T1 Ku70 / p53 /  Pro-B cell lymphoma T(12;15),T(15;12;?) n.d. Yes 2 mo Yes Yes
PK7T2 Ku70 / p53 /  Pro-B cell lymphoma T(12;15) n.d. Yes 3 mo Yes Yes
PK7T3 Ku70 / p53 /  Pro-B cell lymphoma T(12;15),T(15;12;?) n.d. Yes 3 mo Yes Yes
PK7T4 Ku70 / p53 /  Pro-B cell lymphoma n.d. n.d. Yes 2 mo Yes Yes
N10527 Ku80 / p53 / RAD54 /  Pro-B cell lymphoma T(12;15),T(15;12;3) n.d. Yes 1.5 mo Yes Yes
N9984-B Ku80 / p53 / RAD54 /  Pro-B cell lymphoma T(12;15) n.d. Yes 3 mo No No
N9984-T Ku80 / p53 / RAD54 /  Thymic lymphoma T(12;15),T(14;16),Rb(7.18) No n.d. 3 mo No No
N10238 Ku80 / p53 / RAD54 /  Thymic lymphoma T(4;14),T(14;4),T(12;13) No n.d. 3 mo No No
N10449 Ku80 / p53 / RAD54 /  Thymic lymphoma n.d. n.d. n.d. 4 mo No No
N9454 Ku80 / p53 / RAG /  Thymic lymphoma Polyploid, aneuploid No n.d. 3 mo No No
N8839 Ku80 / p53 / RAG /  Thymic lymphoma n.d. n.d. n.d. 3 mo No No
N10611 Ku80 / p53 / RAG /  Thymic lymphoma Polyploid, aneuploid No n.d. 3 mo No No
N10184 Ku80 / p53 / RAG / a Thymic lymphoma Polyploid, aneuploid No n.d. 3 mo No No
N9700 Ku80 / p53 / RAG / a Thymic lymphoma Polyploid, aneuploid No n.d. 4 mo No No
N10214 Ku80 / p53 / RAG / a Thymic lymphoma Polyploid, aneuploid No n.d. 5 mo No No
The immunophenotype as determined by FACS® analysis is indicated for each of the tumors. Due to the instability of some of the tumors, composite
karyotypes represent the most commonly observed clonal aberrations by SKY. Due to the high chromosome instability and polyploid nature of the
Ku/p53/RAG tumors, it was not possible to derive a representative composite karyotype. Ku70 / p53 /  tumors were analyzed with painting probes
specific for chromosomes 12 and 15. Columns labeled TCR and IgH refer to the involvement of these loci in chromosome translocations as
determined by SKY and/or gene specific (Tcr , Tcr , Ig VH, and Ig C ) BAC probes. n.d., not determined.
aMice additionally expressing a rearranged T cell receptor transgene (AND). The AND transgene did not change the age of onset, the type of tumor
or karyotype.472 Mechanisms of Oncogenic Translocation and Gene Amplification
phomas developed in Ku80 / p53 /  mice (Table I).
Chromosome aberrations in Ku80 / p53 / RAG2 / 
thymomas were similar to those reported for p53 /  thy-
momas in that they exhibited polyploidy and aneuploidy,
with very few translocations detectable by SKY analysis
(not shown). We conclude that Rag-mediated cleavage is
essential for the development of pro-B cell lymphomas in
Ku80 / p53 /  mice, but it is dispensable for the develop-
ment of thymomas in Ku80 / p53 / Rag2 /  mice.
Consistent with these results, no B-lineage tumors were
observed in SCIDp53 / Rag2 /  mice of which 43% de-
veloped thymic lymphomas (12).
Recurrent Patterns of Rearrangements, Amplifications and
Telomere Capture in pro-B Cell Lymphomas.  Using a com-
bination of whole-chromosome painting probes, a chro-
mosome 15-specific subtelomeric probe, and probes for
c-myc, IgH C , and IgH C , we found two distinct
types of configurations that juxtaposed IgH and c-myc in
the pro-B cell lymphomas. Although we describe results
for IgH C , identical results were obtained using BAC
clones containing the most JH-proximal constant region
(IgH C ). In the first configuration there is an exchange
of material between chromosomes 12 and 15 resulting in
the formation of two derivative chromosomes, der(12)a
and der(15)a (Fig. 1; scenario A). IgH C  was found near
c-myc on the der(15)a and both genes were coamplified as
determined by FISH and Southern blot analysis (reference
4, Table I, and data not shown). A single copy of the IgH
C  region, however, remained on der (12)a, indicating
that a portion of chromosome 12 had been copied (not
simply translocated) to der(15)a. Additionally, the region
of chromosome 15 telomeric of c-myc was translocated to
the der(12)a and was therefore absent from der(15)a. In
fact, the subtelomeric region of chromosome 15, as indi-
cated by hybridization with a region-specific BAC clone
(15T), was found on the normal 15 [n15] as well as on the
der(12)a (Fig. 1; scenario A). It should be noted that 15T
is absent from the der(15)a. Scenario A–type rearrange-
ments were found in 66% of the tumors analyzed. The al-
ternative rearrangement pathway (Fig. 1; scenario B), was
used by the remainder of the tumors. In these tumors
c-myc and IgH C  were coamplified on the derivative 12
[der(12)b] and no IgH C  signal was detectable on chro-
mosome 15. In fact, both copies of chromosome 15 ap-
peared normal and hybridized with the c-myc and 15T
BAC clones, while der(12)b did not contain any 15T se-
Figure 1. Two types of rearrangement scenarios observed in pro-B cell lymphomas from Ku / p53 /  and Ku / p53 / Rad54 /  mice. In scenarios
A and B, the IgH locus on mouse chromosome 12 and the c-myc locus on mouse chromosome 15 are brought into close proximity with each other. The
top panel contains chromosomes hybridized with chromosome 12 (red) and 15 (green) specific painting probes. Chromosomes 12 (n12) and 15 (n15)
illustrate the normal locations of the probes used in the FISH analysis. In scenario A, der(12)a results from translocation of chromosome 15 (distal to c-myc
[pink]), including the subtelomeric region (15T - red), to chromosome 12. Copying of the IgH C  locus (IgH - green) from chromosome 12 to
chromosome 15 results in der(15)a. In scenario B, both homologues of chromosome 15 usually appear to be intact, whereas copying of the c-myc
oncogene to chromosome 12 results in der(12)b. The extrachromosomal material at the end of the der(12)b is explained in Fig. 5.473 Difilippantonio et al.
quences. In summary, in one class of tumors, IgH C  was
copied and amplified together with c-myc on the der(15)a
(scenario A), whereas in the other class (scenario B) the
c-myc oncogene was copied and amplified together with
IgH C  on der(12)b. These unbalanced rearrangements
and amplifications are much more complex than the re-
ciprocal translocations that juxtapose c-myc and IgH in
human Burkitt’s lymphoma and mouse plasmacytomas
(29) but resemble the gene amplifications typically seen in
solid tumors (30) and multiple myelomas (31).
Hybridization with the 15T BAC implied that the telo-
meric region of chromosome 15 was capping not only the
normal chromosome 15, as expected, but also the der(12)a.
Additionally, while both chromosomes 15 in scenario B
were presumably protected from degradation by chromo-
some 15 telomeric sequences, der(12)b was not (Fig. 1). To
determine if der(15)a and der(12)b were indeed protected
from degradation by telomere sequences and from which
chromosomes these might be derived, we used FISH and
SKY analysis, respectively. In tumors in which IgH C  was
Figure 2. Stabilization of broken chromosomes via chromatid fusion or chromosome capping. (A) Sequences from chromosomes 1, 3, and 16 are
commonly used to cap the derivative chromosome. The presence of DNA from chromosomes 12 or 15 was confirmed by FISH when the region was too
small to be visualized with painting probes. (B) Left panel: copying of the IgH locus onto chromosome 15 leaves der(15)a without a telomere (red) and
results in amplification of both IgH C  (green) and c-myc (pink). Stabilization of this chromosome occurs by the copying of telomeric sequences from
other chromosomes (middle panel: unidentified with chromosome 3 paint; right panel: chromosome 3). (C) Dicentric chromosome stained with DAPI
(blue) and hybridized with probes containing the IgH C  (red) and IgH C  (green) loci.474 Mechanisms of Oncogenic Translocation and Gene Amplification
copied to chromosome 15 (scenario A), additional material
at the ends of der(15)a was often found to be derived from
different chromosomes (Fig. 2 A). Moreover, there were fre-
quently variations in the length and composition at the end
of der(15)a in different metaphases from the same tumor (Fig.
2 B). In some metaphases, the end of der(15)a consisted of
amplified copies of IgH C  and c-myc (Fig. 1, and Fig. 2 B,
left panel); in others there appeared to be a single chromo-
some that capped der (15)a (Fig. 2 A, and Fig. 2 B, middle
and right panels); while in still others we found tandem am-
plification of material from chromosomes 12 and 16 (Fig. 2
A). Additionally, in tumor N10527 we observed cells con-
taining a dicentric chromosome with amplification of the
IgH and c-myc loci (Fig. 2 C). Despite these differences in
chromatin content at the end of der(15)a, all of the
metaphases retained the clonal der(12)a containing 15T se-
quences (Fig. 2 B). The three tumors in scenario B also con-
tained chromatin from chromosomes 1, 3 and/or 16 distal to
the IgH C  and c-myc genes (Fig. 2 A).
A combination of painting probes for chromosomes 3
(green) and 15 (red) and a telomere repeat-specific PNA
probe (white) was used to determine if the additional mate-
rial capping der(15)a contained telomere sequences (Fig. 3).
We observed that in those instances when material
from another chromosome (i.e., chromosome 3) capped
der(15)a, telomere sequences were indeed present (Fig. 3
A). However, when der(15)a was not capped (as in Fig. 2
B, left panel where the end of der(15)a consisted of ampli-
fied copies of IgH C  and c-myc) there was a distinct ab-
sence of telomere sequences (Fig. 3 B). Telomere se-
quences were also observed on the dicentric chromosomes,
but as anticipated only at the two centromeric ends, not at
the internal fusion point (Fig. 3 C). Thus, the derivative
chromosome in which c-myc and IgH are coamplified is
eventually stabilized by the capture of telomeric sequences
from other chromosomes.
Breakpoint Analysis. Because tumors from NHEJ p53
double-deficient mice harbored a recurrent pattern of rear-
rangements and amplifications, we wanted to determine
the precise nature of the breakpoints in the tumors. Using
digestion circularization PCR (DC-PCR; references 4 and
23), we obtained breakpoints from tumors PKT2, PKT7,
and PKT13 (Fig. 4 A). Consistent with the cytogenetic
analysis, DNA sequencing revealed that the cloned rear-
rangements contained sequences from chromosome 12 and
15. Because the break in the IgH gene occurs during V(D)J
recombination, the region of chromosome 12 to which
chromosome 15 sequences were fused appeared near the J
segments of the IgH locus (JH4 for PKT2, JH1 for PKT7
and PKT13; Fig. 4 B). However there was a loss of 45,
208, and 189 bp, respectively, for PKT2, PKT7, and
PKT13 from the original site of the RAG-mediated double
Figure 3. Telomere healing via
chromosome capture. Metaphase
spreads were hybridized with
painting probes specific for
chromosomes 3 (green) and 15
(red) as well as a telomere se-
quence specific PNA probe
(white). (A) The telomere for
der(12)a is provided by chro-
mosome 15, however, der(15)a
requires the capture of a different
chromosome, in this case chro-
mosome 3, in order to obtain
telomere repeat sequences. (B)
Derivative chromosome 15
[der(15)a] with persistent broken
chromatids is not protected from
degradation by telomere repeats.
(C) Telomere-free end fusion
can then result in the formation
of a dicentric chromosome.475 Difilippantonio et al.
strand breakage. The precise position of the breakpoint on
chromosome 15 was obtained by comparing the sequence
of the cloned JH fusion partner with the mouse genome
database (see Materials and Methods). The position of the
breakpoint relative to c-myc was thus readily obtained, and
was 368, 365, and 368 kb telomeric of c-myc for tumors
PKT2, PKT7, and PKT13, respectively. The breakpoints
on chromosome 15 for PKT2 and PKT13 were separated
by only 23 bp (Fig. 4 B). Although we did not observe
cryptic recombination signal sequences near the fusion
points on chromosome 15, there was microhomology at
the junction of chromosomes 12 and 15 in two cases
(PKT2 and PKT7; Fig. 4 A). Taken together, these results
are consistent with the finding that DNA repair in the ab-
sence of NHEJ is imprecise, subject to exonuclease diges-
tion and frequently generated by microhomology-medi-
ated joining (32–34).
As the breakpoints on chromosome 15 for each of the
three tumors clustered within  3 kb of each other, it was
possible that this region contained “fragile” sites for DNA
breakage. To map the breakpoints in other tumors, we
used the chromosome 15-specific sequence from the PKT2
DC-PCR product to design a 23-bp probe for the screen-
ing of a mouse BAC library (see Materials and Methods). A
number of positive clones were identified and mapped to a
contig in the existing mouse database. In particular, clones
Figure 4. Sequence analysis
and localization of fusion points
and rearrangements in the IgH
Ca and c-myc loci. (A) The fusion
points of three Ku80 / p53 / 
pro-B cell lymphomas (PKT no. 2,
7, and 13) were cloned by diges-
tion circularization PCR [der(15)a].
Sequence analysis of the three
breakpoints from scenario A dem-
onstrate microhomology (yellow)
at the junction of chromosomes
12 (red) and 15 (green) in two
cases (PKT2 and PKT7), but none
in tumor PKT13. Homologous
bases outside of this region are also
indicated in uppercase letters. (B)
Sequence analysis implied that
the breakpoint was the V(D)J
recombination signal sequence
(RSS; blue) flanking IgH J1 in
PKT2 and IgH J4 in PKT7 and
PKT13 (top panel); however,
exonuclease digestion of the
cleaved ends resulted in loss of
45, 208, and 189 bp, respectively,
from the original site of the
RAG-mediated DSB to the fusion
point (arrows). Approximate local-
ization of the breakpoints on
chromosome 15 (second panel)
was determined by FISH hybrid-
ization with two BAC clones in
this region (96F18 and 212H11)
as illustrated in Fig. 5. Tumors 1–4,
7, and 13 are from Ku80 / p53 / 
mice, tumors *1–*3 are from
Ku70 / p53 /  mice and tumors
N9984 and N10527 are from
Ku80 / p53 / RAD54 /  mice.
The resulting der(15)a and der(12)b
chromosomes are illustrated in the
bottom panels. In scenario A a
portion of the IgH locus is copied
to chromosome 15 downstream of
c-myc and in the reverse orienta-
tion. In scenario B it appears that
the copying of chromosome 15 to
the der(12)b initiates centromeric
of the c-myc locus and continues
along toward the telomere.476 Mechanisms of Oncogenic Translocation and Gene Amplification
96F18 and 212H11 contained the minimum amount of se-
quence overlap. FISH analysis with these two BACs as well
as BAC clones for IgH C  (17303), c-myc (17312), and
the subtelomeric region of chromosome 15 (15T) revealed
a number of different breakpoints and rearrangement prod-
ucts (Fig. 5). For the tumors classified in scenario A, some
of the breakpoints were mapped within the overlap region
of the two BAC clones (PKT2, KP7T3), others occurred
somewhere within BAC 96F18 (PKT3, PKT4, N10527),
and another occurred either near the centromeric region of
this BAC or in the intervening  170 kb between it and
the c-myc gene (KP7T1; Fig. 5). As both copies of chro-
mosome 15 appear normal for the tumors classified in sce-
nario B (i.e., hybridized with the c-myc, 96F18, 22H11,
and 15T BACs), sequences from this chromosome must
have been copied to the der(12)b. However, it appears that
the amount of chromatin copied varied among the differ-
ent tumors, either stopping centromeric of 96F18 (PKT1)
or continuing past BAC 22H11, but not including the sub-
telomeric region homologous to BAC 15T (KP7T2; Fig.
5). In summary, our analysis of the breakpoints in six differ-
ent pro-B cell tumors (scenario A) revealed that there is not
a single consistent rearrangement site on chromosome 15,
but that multiple breaks occur within the BAC 96F18
chromosomal region which is  170–370 kb from the 3 
end of c-myc. Results from the remaining three tumors
(scenario B) indicated that various amounts of chromosome
15 were copied onto the unresolved V(D)J-induced bro-
ken end of chromosome 12 and that the site of initiation of
DNA synthesis was centromeric to c-myc.
Discussion
Our analysis of lymphomas from knockout mice defi-
cient in NHEJ, HR, V(D)J recombination, and/or p53 has
provided insights into chromosomal rearrangements that
Figure 5. FISH mapping of the chromo-
some 12 and 15 breakpoints in 11 pro-B cell
lymphomas. Top central panel illustrates the
locations of the IgH C  and c-myc loci, two
overlapping BAC clones spanning the
breakpoint in tumor PKT2 (96F18 and
212H11), and the hybridization site of a
chromosome 15 subtelomeric probe (15T)
on normal chromosomes. In the bottom
panels, the breakpoints and rearrangements
in the pro-B cell lymphomas are shown.
The normal chromosomes appear to the far
left (Chr. 12) and right (Chr. 15) of each
box while the derivative chromosomes are
illustrated between them. Arrows on the
normal chromosomes indicate the location
of the rearrangements on the derivative
chromosomes.477 Difilippantonio et al.
are associated with tumor formation during lymphocyte
development. Although we previously demonstrated kary-
otype instability and gross chromosomal aberrations in fi-
broblasts from Ku80-deficient mouse embryos, the rate of
tumorigenesis in these mice is surprisingly low ( 5–10%).
Those thymomas that did arise were distinct from ATM / 
lymphomas (22), but similar to ATM / RAG2 /  thymo-
mas (35), in that chromosome rearrangements involving
the TCR loci were not observed. Similarly, our analysis of
Ku80 / p53 / RAG2 /  and Ku80 / p53 / RAG2 / 
thymic lymphomas revealed the absence of chromosome
rearrangements involving the TCR  or TCR  gene loci.
The polyploidy and aneuploidy of these tumors was very
similar to those observed in p53 /  thymic lymphomas
(36), although Ku80 / p53 / RAG2 /  thymomas arose
at an earlier age (3 mo) than observed in p53 /  mice or
Ku80 /  mice (5–8 mo). Thus, although aberrant rear-
rangements of the TCR locus do not play a causal role in
the development of thymomas in Ku80 /  mice, genomic
instability promoted by absence of Ku80 synergizes with
p53-deficiency to promote early thymomagenesis.
V(D)J recombination does, however, play a direct role in
the development of Ku80 / p53 /  pro-B cell lymphomas
as demonstrated by the proximity of the translocations on
chromosome 12 to the JH loci and the absence of these
tumors in Ku80 / p53 / RAG2 /  mice. We thus dem-
onstrate that RAG-induced DSBs at the IgH gene on
chromosome 12 is the event initiating pro-B cell lym-
phomagenesis in Ku80 / p53 /  mice (Fig. 6, step 1). In
the majority of tumors (scenario A), a DSB is also gener-
ated telomeric to c-myc (Fig. 6, step 2a), as evidenced by
the translocation of the distal portion of chromosome 15 to
the der(12)a (Fig. 6, step 3a). Thus, at least two DSBs are
generated in these tumors, an event which is predicted to
increase the frequency of translocation by several orders of
magnitude relative to a single DSB (1). Our analysis of the
regions involved in the breakpoint on chromosome 15 re-
veals that they cluster  170–370 kb from the 3  end of
c-myc in a region that appears devoid of recombination
signal sequences. It is possible that the clustering reflects the
presence of fragile sites in this region; alternatively, DNA
cleavage on the partner chromosome may be targeted by
RAG-mediated transposition (37, 38), an event that is
stimulated by distorted DNA structures (39). Consistent
with the latter possibility, the fusion points contained a
combination of small inverted repeats and palindromic se-
quences (Fig. 4 A).
Loss of p53 suppresses apoptosis in pro-B cells as evi-
denced by expansion of the pro-B cell compartment in
p53 /  mice (40) and the enhanced survival of pro-B (but
not pro-T) cells in Ku80 / p53 /  mice (4). Furthermore,
the absence of a p53 replication checkpoint would permit
the broken IgH locus to persist into S-phase, allowing for a
replicative repair pathway. The most striking evidence in
Figure 6. Proposed model for
rearrangement events in the
Ku / p53 /  and Ku / p53   
Rad54 /  pro-B cell lymphomas.
RAG proteins initiate DNA DSB
at the IgH D and J gene segments
(step 1). Due to the absence of
the Ku holoenzyme, the DSB
cannot be efficiently and correctly
repaired. The IgH DSB attacks
sequences on chromosome 15. In
scenario A, this results in a DSB
in which the telomeric fragment
of chromosome 15 is translocated
to chromosome 12 while repair of
the lesion on chromosome 15
occurs through a break-induced
replication pathway such that
sequences from chromosome 12
are copied to the der(15)a (steps
2a and 3a). In scenario B, c-myc
is copied to der(12)b without
disruption of the normal chromo-
some 15 (steps 2b and 3b). In
both cases, however, the derivative
chromosome is left with a persistent
DSB. The broken chromatid is
replicated during S-phase (step
4) and the free chromatid ends
are ligated together to form a
bridge (step 5). During mitosis
when the chromatids are separated,
a tug-of-war ensues resulting in
the breaking of the derivative chromosome (step 6). Depending on where the break occurs, one cell may contain a chromosome with amplification
of the genes as an inverted repeat (step 7). Because this chromosome still does not have a telomere sequence, the cycle continues until a telomere is
captured (step 8).478 Mechanisms of Oncogenic Translocation and Gene Amplification
support of replicative repair comes from observations of the
breakpoints by FISH with BAC probes which revealed the
presence of the IgH C  and C  regions on the unrear-
ranged chromosome 12 as well as on both derivative chro-
mosomes 12 [der(12)a] and 15 [der(15)a]. Thus, this region
of the genome was present on three different chromosomes
(Figs. 1 and 2). Furthermore, the relative orientation of
c-myc and IgH loci on der(15)a (Fig. 4 B) suggests that
chromosome 12 was copied from the JH breakpoint to-
ward the centromere onto der(15)a (Fig. 6, steps 2a and 3a).
The same was true of the c-myc locus in scenario B, being
present on both normal copies of chromosome 15 as well as
on the derivative chromosome 12 [der(12)b] (Fig. 6, steps
2b and 3b). Importantly, at least one rearrangement in each
tumor, therefore, cannot be explained by a simple translo-
cation event involving the swapping of material between
two broken chromosomes.
Sequences near a site-specific DSB can invade and copy
sequences from another chromosome, leading to nonrecip-
rocal translocations (41). Replication of the invading DNA
can extend as far as several hundred kilobases to a chromo-
some end (42). These models are consistent with the vary-
ing amount of chromosome 15 copied onto der(12)b in tu-
mors PKT1 and KP7T2. Signon et al. (43) have recently
demonstrated that such a break-induced replication mecha-
nism in yeast occurs in a Rad51- and Rad54-independent
manner, probably mediated by the Rad50/Nbs1/Mre11
repair pathway which utilizes shorter stretches of homol-
ogy. This also is consistent with our findings that pro-B cell
lymphomas from both Ku / p53 /  and Ku80 / p53 / 
Rad54 /  mice had similar chromosome rearrangements.
Despite the absence of significant regions of homology near
the fusion points, we postulate that a break-induced repli-
cation pathway, possibly involving the Rad50/Nbs1/
Mre11 complex, replicates either IgH sequences from
chromosome 12 onto chromosome 15 telomeric of the
c-myc locus (Fig. 6, step 2a) or c-myc sequences onto
chromosome 12 near the site of V(D)J-induced DSB (Fig.
6, step 2b).
Gene amplification through breakage-fusion-bridge cy-
cles is well documented in tissue culture cells (44, 45), and
has been proposed to contribute to tumorigenesis (46). Loss
of DNA damage responsive cell cycle checkpoints (either
by inactivation of p53 or deregulation of c-myc) allows
cells to be permissive to gene amplification in vitro (47–
49). We propose that after completion of break-induced
replication at least one of the chromosomes, namely the
one containing IgH and c-myc, is still free of telomeric se-
quences (Figs. 3 B and 6, step 3). Replication of this “dam-
aged” DNA could be permitted because cells lack the p53-
dependent G1 checkpoint, and results in a chromosome
containing two sister chromatids, each without a telomere
cap (Fig. 6, step 4). The loss of a telomere cap leads to liga-
tion of the free ends and the covalent fusion of the chroma-
tids (50; Fig. 6, step 5). During mitosis when normal sister
chromatids are separated, this particular chromosome en-
counters difficulties because the chromatids are actually one
continuous DNA molecule. The forces exerted by the mi-
totic spindles at the kinetichore usually cause this molecule
to break (Fig. 6, step 6). Depending on where the break
occurs, one of the chromatids may contain two copies of
IgH and c-myc oriented as an inverted repeat (Fig. 2 B)
whereas the other chromatid contains neither of these
genes (Fig. 6, step 7). Observation of dicentric chromo-
somes with multiple copies of the IgH and c-myc genes
between the centromeres (Figs. 2 C and 3 C) further sup-
ports the mechanism of bridge-fusion-breakage in these
gene amplification events.
During the subsequent cell cycle (Fig. 6, dashed lines)
the broken end would be available to enter another round
of break-induced replication, breakage-fusion-bridge, or
both. Evidence for the hypothesis that the missing telo-
meric region is promoting amplification comes from the fact
that the only tumor without amplification, N9984, resulted
in a “simple” translocation event and contains the telomere
of chromosome 15 (Fig. 5). Furthermore, while all
metaphase spreads from the same tumor showed the clonal
T(12,15), individual metaphases exhibited varying degrees
of amplification, and some still did not carry a “telomere
cap” on der(15)a. In these metaphases, repeated cycles of
breakage-fusion-bridge would explain the observed ampli-
fication of IgH/c-myc loci extending to the end of the
chromosome.
Resolution of the breakage-fusion-bridge cycle can oc-
cur when the derivative chromosome is capped by telo-
meric sequences (51). Such capping may also occur by
break-induced replication (Fig. 6, step 8). Why chromo-
somes 1, 3 and 16 (Fig. 2) are consistently used for the pur-
pose of telomere capture remains to be determined; how-
ever, one can postulate that they either harbor sequences
which are homologous to chromosomes 12 or 15, are in
close proximity within the nucleus or a combination of
these two possibilities.
A similar question is often raised as to why c-myc is the
oncogene so frequently observed in juxtaposition with IgH
in tumors of B cell origin. Given the fact that there are
around 1.4   106 B220    pro-B cells in the bone mar-
row (BM) of p53-deficient mice (40), a one in a million
event would be sufficient to give rise to a tumor precursor
cell in which the IgH enhancer drives expression of the
c-myc oncogene. Yu and Thomas-Tikhonenko injected
BM cells from p53 /  mice into syngeneic recipients after
infecting them with a c-myc expressing retrovirus (52).
Given their 60% infection rate, the  600,000 c-myc ex-
pressing BM cells gave rise to tumors within 5 weeks post-
injection. Only 19 cell divisions would be required to get
from a one in a million precursor cell to the 600,000 cells
injected into these mice. At one cell division per day, a pre-
cursor cell in a newborn mouse could give rise to a pro-B
cell lymphoma within 8 wk, a time consistent with our
observations in Ku/p53-deficient mice. Thus, one need
not postulate that the region near c-myc is particularly
prone to rearrangement with the IgH locus, but that this
extremely random event juxtaposing c-myc and IgH is suf-
ficient to allow cell survival. Subsequent amplification of
this rearranged locus and deregulation of c-myc expression479 Difilippantonio et al.
would then allow for the rapid expansion of this cell into a
tumor population.
In summary, the Ku / p53 /  mouse provides a genetic
system in which the etiology of chromosomal aberrations
in the absence of NHEJ can be studied. We demonstrate
that the formation of oncogenic nonreciprocal transloca-
tions and amplifications in NHEJ-deficient cells are trig-
gered by a Rad54-independent break-induced replication
mechanism that involves invasion of a heterologous chro-
mosome using DSBs created through RAG-mediated
cleavage. The subsequent amplification of c-myc/IgH re-
sults from cycles of bridge-fusion-breakage. Resolution and
protection from exonucleolytic degradation is eventually
achieved when the recombinogenic chromatid ends invade
and copy sequences from an unbroken chromosome con-
taining a telomere. The resultant nonreciprocal transloca-
tion and gene amplifications resemble the complex cytoge-
netic profiles frequently observed in human cancers. Ku / 
p53 /  mice will therefore serve as useful model systems
for further studies aimed at elucidating the genetic require-
ments of replication-based recombination mechanisms
leading to malignancy.
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